CL2011002973A1 - Metodo para detectar anticuerpos en una muestra que comprende contactar una muestra con un soporte que tiene fijado un peptoide; kit para detectar anticuerpos que son indicativos de una enfermedad neurodegenerativa. - Google Patents

Metodo para detectar anticuerpos en una muestra que comprende contactar una muestra con un soporte que tiene fijado un peptoide; kit para detectar anticuerpos que son indicativos de una enfermedad neurodegenerativa.

Info

Publication number
CL2011002973A1
CL2011002973A1 CL2011002973A CL2011002973A CL2011002973A1 CL 2011002973 A1 CL2011002973 A1 CL 2011002973A1 CL 2011002973 A CL2011002973 A CL 2011002973A CL 2011002973 A CL2011002973 A CL 2011002973A CL 2011002973 A1 CL2011002973 A1 CL 2011002973A1
Authority
CL
Chile
Prior art keywords
sample
antibodies
peptoid
indicative
kit
Prior art date
Application number
CL2011002973A
Other languages
English (en)
Inventor
Reddy Moola
Dwight Connel Steven Wilson Rosemary Wilson Johnnie Kodadek Thomas German
Original Assignee
Opko Health Inc
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42269525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011002973(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Opko Health Inc, Univ Texas filed Critical Opko Health Inc
Publication of CL2011002973A1 publication Critical patent/CL2011002973A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Método para detectar anticuerpos en una muestra que comprende contactar una muestra con un soporte que tiene fijado un peptoide; kit para detectar anticuerpos que son indicativos de una enfermedad neurodegenerativa.
CL2011002973A 2009-06-02 2011-11-24 Metodo para detectar anticuerpos en una muestra que comprende contactar una muestra con un soporte que tiene fijado un peptoide; kit para detectar anticuerpos que son indicativos de una enfermedad neurodegenerativa. CL2011002973A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18326009P 2009-06-02 2009-06-02
US31865510P 2010-03-29 2010-03-29

Publications (1)

Publication Number Publication Date
CL2011002973A1 true CL2011002973A1 (es) 2012-03-23

Family

ID=42269525

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011002973A CL2011002973A1 (es) 2009-06-02 2011-11-24 Metodo para detectar anticuerpos en una muestra que comprende contactar una muestra con un soporte que tiene fijado un peptoide; kit para detectar anticuerpos que son indicativos de una enfermedad neurodegenerativa.

Country Status (16)

Country Link
US (1) US9551721B2 (es)
EP (1) EP2438444A1 (es)
JP (1) JP5828837B2 (es)
KR (1) KR20120122869A (es)
CN (1) CN102439451B (es)
AU (1) AU2010256880B2 (es)
BR (1) BRPI1013012A2 (es)
CA (1) CA2764153C (es)
CL (1) CL2011002973A1 (es)
CO (1) CO6450654A2 (es)
HK (1) HK1169709A1 (es)
IL (1) IL216689A (es)
MX (1) MX2011012933A (es)
RU (1) RU2566064C2 (es)
TW (1) TWI569014B (es)
WO (1) WO2010141421A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014504594A (ja) 2011-01-10 2014-02-24 オプコ ファーマシューティカルズ、エルエルシー 自己免疫疾患における抗原代用物
KR20140027174A (ko) * 2011-03-24 2014-03-06 옵코 파마슈티칼스, 엘엘씨 비드 또는 입자 기초 라이브러리들, 진단적 키트들을 및 치료제들을 사용한 복합 생물학적 유체에서 바이오마커 발견
WO2012154484A1 (en) * 2011-05-06 2012-11-15 Elwha Llc Compositions and methods for antibody and ligand identification
US11360098B2 (en) * 2015-09-28 2022-06-14 Quest Diagnostics Investments Llc Amyloid beta detection by mass spectrometry
SG11201802777XA (en) 2015-10-14 2018-05-30 X Therma Inc Compositions and methods for reducing ice crystal formation
JP7026643B2 (ja) * 2016-03-09 2022-02-28 マイク－アン、エルエルシー ペプトイド親和性リガンド
CN109641935A (zh) * 2016-03-25 2019-04-16 莫拉利达尔·瑞迪·穆拉 组合合成和生物标志物开发
CN106866794B (zh) * 2017-02-15 2020-09-08 国家纳米科学中心 一种类肽及其制备方法和应用
CN108484905A (zh) * 2018-04-16 2018-09-04 青岛科技大学 一种侧链含羧基具有ucst行为的聚类肽及其制备方法
WO2019211878A1 (en) * 2018-05-04 2019-11-07 Council Of Scientific And Industrial Research, An Indian Registered Body Incorporated Under The Registration Of Societies Act (Act Xxi Of 1860) Peptoid of formula i, pharmaceutical compositions and method for preparation thereof
CN108586579B (zh) * 2018-05-11 2021-11-30 京东方科技集团股份有限公司 一种类肽及其衍生物、盐、制备方法和用途

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4789628A (en) * 1986-06-16 1988-12-06 Vxr, Inc. Devices for carrying out ligand/anti-ligand assays, methods of using such devices and diagnostic reagents and kits incorporating such devices
CA1304682C (en) 1986-11-19 1992-07-07 Nobuo Monji Membrane affinity concentration immunoassay
US5149626A (en) * 1987-05-14 1992-09-22 Mclean Hospital Corporation Multiple antigen immunoassay
ATE128716T1 (de) 1987-11-24 1995-10-15 Abbott Lab Hiv-peptide und methoden für den nachweis von hiv.
DE4040669A1 (de) 1990-12-19 1992-06-25 Behringwerke Ag Verwendung von peptidpaaren mit extrem hoher spezifischer affinitaet zueinander im bereich der in vitro diagnostik
DK51092D0 (da) 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
CA2115333A1 (en) * 1993-02-16 1994-08-17 Shigeo Hozumi Polyfunctional vinyl ether compounds and photoresist resin composition containing the same
US5705614A (en) * 1993-04-09 1998-01-06 Chiron Corporation Methods of producing antigen forks
DK0700521T3 (da) * 1993-05-28 2003-09-29 Baylor College Medicine Fremgangsmåde og massespektrometer til desorption og ionisering af analysander
ZA95605B (en) * 1994-04-28 1995-12-20 Qualcomm Inc Method and apparatus for automatic gain control and dc offset cancellation in quadrature receiver
AUPO591797A0 (en) * 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
EP2338897A1 (en) * 1995-06-07 2011-06-29 Glaxo Group Limited Peptides and compounds that bind to a thrombopoietin receptor
JPH1025299A (ja) 1996-07-12 1998-01-27 Nec Corp 整列ペプチド、及びそれを用いたタンパク質の結合・相互作用部位検出方法
US20020006620A1 (en) * 1996-10-17 2002-01-17 Invitrogen Corporation Morphatides: novel shape and structure libraries
US20020022227A1 (en) * 1996-10-17 2002-02-21 Short Jay M. Morphatides: novel shape and structure libraries
US6153596A (en) * 1996-12-18 2000-11-28 Emory University Polycationic oligomers
WO1998046796A1 (en) * 1997-04-11 1998-10-22 The Regents Of The University Of California A method of screening nucleotide sequences to identify disruptors or effectors of biological processes or pathways
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
IL138668A0 (en) 1998-04-03 2001-10-31 Phylos Inc Addressable protein arrays
US6406632B1 (en) * 1998-04-03 2002-06-18 Symyx Technologies, Inc. Rapid characterization of polymers
US6297059B1 (en) * 1998-06-22 2001-10-02 The Regents Of The University Of California Triggered optical biosensor
US6780582B1 (en) * 1998-07-14 2004-08-24 Zyomyx, Inc. Arrays of protein-capture agents and methods of use thereof
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
US6306643B1 (en) * 1998-08-24 2001-10-23 Affymetrix, Inc. Methods of using an array of pooled probes in genetic analysis
EP2333064A1 (en) * 1998-11-06 2011-06-15 University of Zürich Nucleotide and protein sequences of Nogo genes and methods based thereon
WO2000056934A1 (en) 1999-03-24 2000-09-28 Packard Bioscience Company Continuous porous matrix arrays
US6465183B2 (en) * 1999-07-01 2002-10-15 Agilent Technologies, Inc. Multidentate arrays
EP1224463A2 (en) * 1999-10-08 2002-07-24 Superarray, Inc. Compositions and methods for detecting protein modification and enzymatic activity
EP1155327A1 (en) * 1999-11-02 2001-11-21 Chiron Corporation Biological sample component purification and differential display
AU2001233276A1 (en) 2000-02-03 2001-08-14 Immunomatrix Inc. Method and apparatus for signal transduction pathway profiling
US6887845B2 (en) 2000-02-16 2005-05-03 Northwestern University Polypeptoid pulmonary surfactants
WO2001069258A1 (en) 2000-03-16 2001-09-20 Biacore Ab Method for capturing analytes eluted from surface-bound ligands
JP2004501869A (ja) * 2000-03-22 2004-01-22 ソルリンク・インコーポレイテッド ヒドラジンベース及びカルボニルベースの二官能性架橋剤
KR20040010041A (ko) * 2000-05-04 2004-01-31 예일 유니버시티 단백질 활성의 스크리닝을 위한 고밀도 단백질 어레이
AU2001261533A1 (en) 2000-05-12 2001-11-26 Dumas, David P Compositions and methods for epitope mapping
US20020108130A1 (en) * 2000-05-25 2002-08-08 Asher Nathan Extracellular drug-oligonucleotides chimeric molecules
ES2281424T3 (es) * 2000-06-05 2007-10-01 Novartis Vaccines And Diagnostics, Inc. Micromatrices para llevar a cabo analisis proteomicos.
US7148058B2 (en) 2000-06-05 2006-12-12 Chiron Corporation Protein microarrays on mirrored surfaces for performing proteomic analyses
US7153682B2 (en) 2000-06-05 2006-12-26 Chiron Corporation Microarrays on mirrored substrates for performing proteomic analyses
US20020013334A1 (en) * 2000-06-15 2002-01-31 Robl Jeffrey A. HMG-CoA reductase inhibitors and method
DK1292710T3 (da) 2000-06-23 2007-12-27 Domantis Ltd Fremgangsmåde til matrix-screening
ES2266224T3 (es) * 2000-08-15 2007-03-01 Discerna Limited Series de proteinas funcionales.
AU2001285252A1 (en) 2000-08-25 2002-03-13 Gendaq, Ltd. Analysis of binding interactions
GB0022978D0 (en) * 2000-09-19 2000-11-01 Oxford Glycosciences Uk Ltd Detection of peptides
EP1197755A1 (en) 2000-10-11 2002-04-17 Pepscan Systems B.V. Identification of protein binding sites
WO2002040716A2 (en) * 2000-11-16 2002-05-23 Cemines, Llc Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
US20020137104A1 (en) 2000-11-27 2002-09-26 Antonio Cosma High throughput determination of antigen expression
WO2002048403A2 (en) * 2000-12-11 2002-06-20 Hk Pharmaceuticals, Inc. Multiplexed protein expression and activity assay
WO2002059601A1 (en) * 2001-01-23 2002-08-01 President And Fellows Of Harvard College Nucleic-acid programmable protein arrays
JP2004531700A (ja) 2001-02-05 2004-10-14 グラフィニティー、ファーマスーティカルス アーゲー 低親和性スクリーニング法
US20020137106A1 (en) * 2001-03-09 2002-09-26 Ciphergen Biosystems, Inc. Detection of biological pathway components
WO2002073209A2 (de) 2001-03-10 2002-09-19 Affina Immuntechnik Gmbh Verfahren zur identifikation von immunreaktiven epitopen auf proteinen
CA2443777A1 (en) * 2001-04-10 2002-10-24 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles
WO2002084252A2 (en) * 2001-04-17 2002-10-24 Xenoport, Inc. Epitope-captured antibody display
EP1379545A2 (de) * 2001-04-19 2004-01-14 Gesellschaft für biotechnologische Forschung mbH (GBF) Verfahren zur herstellung stabiler, regenerierbarer antikörper-arrays
US6989276B2 (en) * 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
WO2003019192A1 (en) * 2001-08-27 2003-03-06 The Trustees Of Boston University Apparatus, composition and method for proteome profiling
AU2002367732A1 (en) 2001-10-31 2003-09-09 Children's Hospital Medical Center Method for diagnosis and treatment of rheumatoid arthritis
EP1319954A1 (en) 2001-12-12 2003-06-18 Centre National de Genotypage Methods for protein analysis using protein capture arrays
US7504364B2 (en) 2002-03-01 2009-03-17 Receptors Llc Methods of making arrays and artificial receptors
AU2003219477A1 (en) 2002-03-07 2003-09-16 Zephyr Proteomix Ltd. Microarrays of cellulose binding chimeric proteins and methods of use thereof
US7736909B2 (en) * 2003-01-09 2010-06-15 Board Of Regents, The University Of Texas System Methods and compositions comprising capture agents
US7794947B2 (en) 2003-07-10 2010-09-14 Institute For Systems Biology Affinity capture of peptides by microarray and related methods
GB2404734A (en) 2003-08-05 2005-02-09 Secr Defence A method of screening a sample for abnormally glycosylated and/or expressed proteins
WO2006028930A2 (en) * 2004-09-03 2006-03-16 Receptors Llc Combinatorial artificial receptors including tether building blocks on scaffolds
EP1688137A1 (en) * 2005-01-28 2006-08-09 Schwarz Pharma Ag SPM 927 for add-on therapy of schizophrenia
WO2006124644A2 (en) * 2005-05-12 2006-11-23 Board Of Regents, The University Of Texas System Protein and antibody profiling using small molecule microarrays
US7834144B2 (en) 2005-09-09 2010-11-16 Novartis Ag Prion-specific peptoid reagents
US20110143953A1 (en) 2006-10-16 2011-06-16 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Synthetic Antibodies
KR20120034683A (ko) 2009-05-29 2012-04-12 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 자가면역 ｔ-세포의 분리 및 처리를 위한 펩토이드 리간드

Also Published As

Publication number Publication date
US9551721B2 (en) 2017-01-24
EP2438444A1 (en) 2012-04-11
MX2011012933A (es) 2012-03-07
CN102439451A (zh) 2012-05-02
IL216689A0 (en) 2012-02-29
KR20120122869A (ko) 2012-11-07
TWI569014B (zh) 2017-02-01
US20100303805A1 (en) 2010-12-02
HK1169709A1 (en) 2013-02-01
JP2012529053A (ja) 2012-11-15
AU2010256880A1 (en) 2011-11-03
IL216689A (en) 2016-09-29
JP5828837B2 (ja) 2015-12-09
TW201109662A (en) 2011-03-16
RU2566064C2 (ru) 2015-10-20
BRPI1013012A2 (pt) 2016-10-18
WO2010141421A1 (en) 2010-12-09
AU2010256880B2 (en) 2015-01-22
CN102439451B (zh) 2014-12-03
CA2764153A1 (en) 2010-12-09
CA2764153C (en) 2021-07-27
CO6450654A2 (es) 2012-05-31

Similar Documents

Publication Publication Date Title
CL2011002973A1 (es) Metodo para detectar anticuerpos en una muestra que comprende contactar una muestra con un soporte que tiene fijado un peptoide; kit para detectar anticuerpos que son indicativos de una enfermedad neurodegenerativa.
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EA201590027A1 (ru) Способы детекции заболеваний или состояний
CL2012002741A1 (es) Metodo para determinar en una muestra de sangre la presencia de vitamina d libre; inmunoensayo para detrminar presencia de vitamina d libre en sangre; kit para efectuar inmunoensayo.
EP2404162A4 (en) DETECTION SYSTEM AND METHOD FOR HIGH SENSITIVITY FLUORESCENT ASSAYS
BRPI0922885A2 (pt) anticorpos humanos de alta afinidade para a pcsk9.
CL2012003375A1 (es) Anticuerpo monoclonal que se une a enzima ariloxialcanoato dioxigenasa (aad-12); linea celular de hibridomas que produce dicho anticuerpo; metodos para detectar la presencia de la enzima aad-12; metodo para la deteccion cuantitativa de una enzima aad-12.
BRPI0923199A2 (pt) métodos e composições para detecção de anticorpos com fixação de complemento.
BRPI1008156A2 (pt) sistema de vedação dupla para uso com uma sonda
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
BRPI0915086A2 (pt) detecção do uso de canabis
BRPI1009269A2 (pt) biomarcadores de envelhecimento específicos do tecido.
CL2013000813A1 (es) Dispositivo inmunocromatográfico que comprende una membrana que tiene un anticuerpo capaz de unirse a una proteina z-aat presente en una muestra de un portador del gen piz; metodo para determinar un portador del gen piz; metodo para diagnosticar una afección o enfermedad asociada con la deficiencia de aat; kits de inmunocromatografia
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
BRPI1013070A2 (pt) conexão de tubo com testes de pressão
JP2010048806A5 (ja) 流体内検体濃度検知システム
BRPI1006731A2 (pt) configuração de sistema para realizar um teste de potencial de metano biológico em uma bioamostra, configuração de sistema para medir o gás biometano em um fluxo de biogás e método para medir o potencial de metano biológico de uma bioamostra
BRPI0911371A2 (pt) método de determinação do prognóstico de funcionamento de um sistema
CL2012001353A1 (es) Método de detección de un evento de soja en una muestra basada en poner en contacto dicha muestra con un polinucleótido específico para el evento aad-12 pdab4468-0416; método para determinar cigocidad de dicho evento en una planta de soja y kit de detección de adn.
BR112012015266A2 (pt) dispositivo configurado para receber uma amostra e método para determinar a presença de um analito em uma amostra
BRPI1009573A2 (pt) método para avaliar uma condição artrítica em um sujeito, kit para detectar a presença de um auto-anticorpo, e, método para determinar o subtipo de artrite em um paciente.
CL2011002260A1 (es) Metodo o sistema para el seguimiento del tratamiento de un individuo que comprende determinar si una muestra de dicho individuo comprende un biomarcador.
BRPI1015458A2 (pt) método para detectar anticorpo contra sith-1 em amostra biológica
CL2011003218A1 (es) Metodo para determinar la susceptibilidad de un sujeto a un virus; metodo para detectar replicacion viral en una muestra de tejido; en aves y salmon.
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.